Economic analyses in clinical trials for cooperative groups

Operational considerations

Charles L. Bennett, Teresa Waters

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Clinical trials have served as valuable tools for evaluating new therapeutic strategies in the treatment of cancer. Traditionally, new pharmaceuticals and procedures have been appraised on the basis of effectiveness, efficacy, and safety. Recently, economic concerns have become increasingly important when considering treatment strategies for cancer patients. The national emphasis on assessing the costs of health care has focused primarily on the cost-effectiveness of resource allocation. Policy makers are exhibiting greater interest in economic data to supplement clinical data of new procedures and pharmaceutical agents before the approval and widespread application of such methodologies. Clinical trials have increasingly become viewed as a proper setting for such economic analyses. In this paper; we review operational details for carrying out economic analyses of clinical trials being conducted in the cancer cooperative group setting.

Original languageEnglish (US)
Pages (from-to)448-453
Number of pages6
JournalCancer Investigation
Volume15
Issue number5
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Economics
Clinical Trials
Neoplasms
Resource Allocation
Administrative Personnel
Pharmaceutical Preparations
Health Care Costs
Cost-Benefit Analysis
Therapeutics
Safety

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Economic analyses in clinical trials for cooperative groups : Operational considerations. / Bennett, Charles L.; Waters, Teresa.

In: Cancer Investigation, Vol. 15, No. 5, 01.01.1997, p. 448-453.

Research output: Contribution to journalArticle

@article{d8b6b280b1964c40be860e1e8b213ffe,
title = "Economic analyses in clinical trials for cooperative groups: Operational considerations",
abstract = "Clinical trials have served as valuable tools for evaluating new therapeutic strategies in the treatment of cancer. Traditionally, new pharmaceuticals and procedures have been appraised on the basis of effectiveness, efficacy, and safety. Recently, economic concerns have become increasingly important when considering treatment strategies for cancer patients. The national emphasis on assessing the costs of health care has focused primarily on the cost-effectiveness of resource allocation. Policy makers are exhibiting greater interest in economic data to supplement clinical data of new procedures and pharmaceutical agents before the approval and widespread application of such methodologies. Clinical trials have increasingly become viewed as a proper setting for such economic analyses. In this paper; we review operational details for carrying out economic analyses of clinical trials being conducted in the cancer cooperative group setting.",
author = "Bennett, {Charles L.} and Teresa Waters",
year = "1997",
month = "1",
day = "1",
doi = "10.3109/07357909709047584",
language = "English (US)",
volume = "15",
pages = "448--453",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Economic analyses in clinical trials for cooperative groups

T2 - Operational considerations

AU - Bennett, Charles L.

AU - Waters, Teresa

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Clinical trials have served as valuable tools for evaluating new therapeutic strategies in the treatment of cancer. Traditionally, new pharmaceuticals and procedures have been appraised on the basis of effectiveness, efficacy, and safety. Recently, economic concerns have become increasingly important when considering treatment strategies for cancer patients. The national emphasis on assessing the costs of health care has focused primarily on the cost-effectiveness of resource allocation. Policy makers are exhibiting greater interest in economic data to supplement clinical data of new procedures and pharmaceutical agents before the approval and widespread application of such methodologies. Clinical trials have increasingly become viewed as a proper setting for such economic analyses. In this paper; we review operational details for carrying out economic analyses of clinical trials being conducted in the cancer cooperative group setting.

AB - Clinical trials have served as valuable tools for evaluating new therapeutic strategies in the treatment of cancer. Traditionally, new pharmaceuticals and procedures have been appraised on the basis of effectiveness, efficacy, and safety. Recently, economic concerns have become increasingly important when considering treatment strategies for cancer patients. The national emphasis on assessing the costs of health care has focused primarily on the cost-effectiveness of resource allocation. Policy makers are exhibiting greater interest in economic data to supplement clinical data of new procedures and pharmaceutical agents before the approval and widespread application of such methodologies. Clinical trials have increasingly become viewed as a proper setting for such economic analyses. In this paper; we review operational details for carrying out economic analyses of clinical trials being conducted in the cancer cooperative group setting.

UR - http://www.scopus.com/inward/record.url?scp=0030882072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030882072&partnerID=8YFLogxK

U2 - 10.3109/07357909709047584

DO - 10.3109/07357909709047584

M3 - Article

VL - 15

SP - 448

EP - 453

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 5

ER -